claim: aprotinin (s sars-cov-2 replication
evidence_1: in conclusion, therapeutic aprotinin concentrations exert anti-sars-cov-2 activity.", "herein, we showed that the protease inhibitor aprotinin (but not the protease inhibitor serpina1/alpha-1 antitrypsin) inhibited sars-cov-2 replication in therapeutically achievable concentrations.", "aprotinin displayed anti-sars-cov-2 activity in different cell types (caco2, calu-3, and primary bronchial epithelial cell air-liquid interface cultures) and against four virus isolates.")